A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma

被引:51
作者
Guo, Wenna [1 ]
Zhu, Liucun [2 ]
Zhu, Rui [2 ]
Chen, Qihan [1 ]
Wang, Qiang [1 ]
Chen, Jian-Qun [1 ]
机构
[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China
[2] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
PROMOTER METHYLATION; CANCER; DISEASE; GENES; RECURRENCE; MECHANISMS; PROGNOSIS; DNA;
D O I
10.7554/eLife.44310
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cutaneous melanoma (CM) is a life-threatening form of skin cancer. Prognostic biomarkers can reliably stratify patients at initial melanoma diagnosis according to risk, and may inform clinical decisions. Here, we performed a retrospective, cohort-based study analyzing genome-wide DNA methylation of 461 patients with CM from the TCGA database. Cox regression analyses were conducted to establish a four-DNA methylation signature that was significantly associated with the overall survival (OS) of patients with CM, and that was validated in an independent cohort. Corresponding Kaplan-Meier analysis displayed a distinct separation in OS. The ROC analysis confirmed that the predictive signature performed well. Notably, this signature exhibited much higher predictive accuracy in comparison with known biomarkers. This signature was significantly correlated with immune checkpoint blockade (ICB) immunotherapy-related signatures, and may have potential as a guide for measures of responsiveness to ICB immunotherapy.
引用
收藏
页数:19
相关论文
共 51 条
[1]   Genomic Classification of Cutaneous Melanoma [J].
Akbani, Rehan ;
Akdemir, Kadir C. ;
Aksoy, B. Arman ;
Albert, Monique ;
Ally, Adrian ;
Amin, Samirkumar B. ;
Arachchi, Harindra ;
Arora, Arshi ;
Auman, J. Todd ;
Ayala, Brenda ;
Baboud, Julien ;
Balasundaram, Miruna ;
Balu, Saianand ;
Barnabas, Nandita ;
Bartlett, John ;
Bartlett, Pam ;
Bastian, Boris C. ;
Baylin, Stephen B. ;
Behera, Madhusmita ;
Belyaev, Dmitry ;
Benz, Christopher ;
Bernard, Brady ;
Beroukhim, Rameen ;
Bir, Natalie ;
Black, Aaron D. ;
Bodenheimer, Tom ;
Boice, Lori ;
Boland, Genevieve M. ;
Bono, Riccardo ;
Bootwalla, Moiz S. ;
Bosenberg, Marcus ;
Bowen, Jay ;
Bowlby, Reanne ;
Bristow, Christopher A. ;
Brockway-Lunardi, Laura ;
Brooks, Denise ;
Brzezinski, Jakub ;
Bshara, Wiam ;
Buda, Elizabeth ;
Burns, William R. ;
Butterfield, Yaron S. N. ;
Button, Michael ;
Calderone, Tiffany ;
Cappellini, Giancarlo Antonini ;
Carter, Candace ;
Carter, Scott L. ;
Cherney, Lynn ;
Cherniack, Andrew D. ;
Chevalier, Aaron ;
Chin, Lynda .
CELL, 2015, 161 (07) :1681-1696
[2]   GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer [J].
Akiyama, Y ;
Watkins, N ;
Suzuki, H ;
Jair, KW ;
van Engeland, M ;
Esteller, M ;
Sakai, H ;
Ren, CY ;
Yuasa, Y ;
Herman, JG ;
Baylin, SB .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (23) :8429-8439
[3]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[4]   Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas [J].
Cesinaro, A. M. ;
Sartori, G. ;
Migaldi, M. ;
Schirosi, L. ;
Pellacani, G. ;
Collina, G. ;
Maiorana, A. .
PATHOLOGY, 2012, 44 (04) :313-317
[5]   Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression [J].
Chang, Chih-Hao ;
Qiu, Jing ;
O'Sullivan, David ;
Buck, Michael D. ;
Noguchi, Takuro ;
Curtis, Jonathan D. ;
Chen, Qiongyu ;
Gindin, Mariel ;
Gubin, Matthew M. ;
van der Windt, Gerritje J. W. ;
Tonc, Elena ;
Schreiber, Robert D. ;
Pearce, Edward J. ;
Pearce, Erika L. .
CELL, 2015, 162 (06) :1229-1241
[6]   Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation [J].
Chen, Jian ;
Song, Wenfeng ;
Du, Yehui ;
Li, Zequn ;
Xuan, Zefeng ;
Zhao, Long ;
Chen, Jun ;
Zhao, Yongchao ;
Tuo, Biguang ;
Zheng, Shusen ;
Song, Penghong .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 499 (03) :433-440
[7]   Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments [J].
Chen, Xijia ;
Guo, Wenna ;
Xu, Xin-jian ;
Su, Fangchu ;
Wang, Yi ;
Zhang, Yingzheng ;
Wang, Qiang ;
Zhu, Liucun .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 85 (03) :226-234
[8]   Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma [J].
Cheng, Phil F. ;
Shakhova, Olga ;
Widmer, Daniel S. ;
Eichhoff, Ossia M. ;
Zingg, Daniel ;
Frommel, Sandra C. ;
Belloni, Benedetta ;
Raaijmakers, Marieke I. G. ;
Goldinger, Simone M. ;
Santoro, Raffaella ;
Hemmi, Silvio ;
Sommer, Lukas ;
Dummer, Reinhard ;
Levesque, Mitchell P. .
GENOME BIOLOGY, 2015, 16
[9]   Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness [J].
Cho, Shu-Huei ;
Kuo, I-Ying ;
Lu, Pei-Jung Frank ;
Tzeng, Hong-Tai ;
Lai, Wu-Wei ;
Su, Wu-Chou ;
Wang, Yi-Ching .
CELL DEATH & DISEASE, 2018, 9
[10]   Cutaneous MelanomaA Long Road from Experimental Models to Clinical Outcome: A Review [J].
Coricovac, Dorina ;
Dehelean, Cristina ;
Moaca, Elena-Alina ;
Pinzaru, Iulia ;
Bratu, Tiberiu ;
Navolan, Dan ;
Boruga, Ovidiu .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)